RecruitingNot applicableNCT06477263

NeuroCytotron in the Treatment of Autism Spectrum Disorder

Studying Interatrial communication

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neurocytonix, Inc.
Principal Investigator
J R Trujillo
jrtrujillo@neurocytonix.com
Intervention
Neurocytotron(device)
Enrollment
100 target
Eligibility
3-50 years · All sexes
Timeline
2024 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06477263 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials